These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 1578304

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Accelerated growth following treatment of children with chronic renal failure with recombinant human growth hormone (somatrem): a preliminary report.
    Lippe B, Fine RN, Koch VH, Sherman BM.
    Acta Paediatr Scand Suppl; 1988; 343():127-31. PubMed ID: 3057804
    [Abstract] [Full Text] [Related]

  • 24. High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc., Cooperative Study Group.
    Mauras N, Attie KM, Reiter EO, Saenger P, Baptista J.
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3653-60. PubMed ID: 11061518
    [Abstract] [Full Text] [Related]

  • 25. Identification of short stature caused by SHOX defects and therapeutic effect of recombinant human growth hormone.
    Binder G, Schwarze CP, Ranke MB.
    J Clin Endocrinol Metab; 2000 Jan; 85(1):245-9. PubMed ID: 10634394
    [Abstract] [Full Text] [Related]

  • 26. Effects of two years of growth hormone treatment in short, slowly growing non-growth hormone deficient children.
    Lanes R.
    J Pediatr Endocrinol Metab; 1995 Jan; 8(3):167-71. PubMed ID: 8521190
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Treatment with a luteinizing hormone-releasing hormone agonist in adolescents with short stature.
    Yanovski JA, Rose SR, Municchi G, Pescovitz OH, Hill SC, Cassorla FG, Cutler GB.
    N Engl J Med; 2003 Mar 06; 348(10):908-17. PubMed ID: 12621135
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Effects of growth hormone treatment on body proportions and final height among small children with X-linked hypophosphatemic rickets.
    Haffner D, Nissel R, Wühl E, Mehls O.
    Pediatrics; 2004 Jun 06; 113(6):e593-6. PubMed ID: 15173542
    [Abstract] [Full Text] [Related]

  • 40. Effects of 3 years of growth hormone therapy in short normal children.
    Hindmarsh PC, Pringle PJ, Di Silvio L, Brook CG.
    Acta Paediatr Scand Suppl; 1990 Jun 06; 366():6-12; discussion 13. PubMed ID: 2206007
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.